News Conference

ACS Boston 2018: Day 2

All this week, MedChemNet is bringing you content direct from the National Meeting and Exposition of the American Chemical Society in Boston; take a look at some of our highlights.

Go to the profile of MedChemNet
Aug 20, 2018
0
0
Like 0 Comment
Daily update

Highlights of the exposition!

It's been another busy day here in Boston! We've explored the exposition, tracked down the best goodies and met lots and lots of fantastic members - thanks for dropping by. 

Talk highlights included a stream on treating rare diseases using new chemical advances, featuring Xueqing Wang (Pharmacyclics, CA, USA) discussing the discovery of CFTR correctors for the treatment of cystic fibrosis, while another stream highlighted novel treatments to combat chronic pain and confront the opioid epidemic.  Another highlight of the day was the watching The Tetrahedron Prize being awarded to Laura Kiessling (MIT, MA, USA), who then presented her fascinating research on carbohydrates as microbial IDs. 
Video of the day

Jasmine Harris, Editor (London, UK)
Picture of the DayTomorrow's key talk
Emerging Trends in Target Identification
We got our photo taken with Professor Molenium and Meg-A-Mole!Room 210A, Boston Convention and Exhibition Center
1:30pm
Today's news highlights
Anticancer strategies: can we prevent severe oral mucositis?Tackling mosquito-borne diseases with next-generation insect repellents
Research presented at the 265th National Meeting and Exposition of the American Chemical Society (19–23 August 2018) suggests a new drug could prevent a common debilitating side effect of cancer treatment.At the 256th ACS National Meeting and Exhibition (19–23 August 2018), Iowa State University researchers report a new class of insect repellents that could help combat mosquito-borne diseases.
Go to the profile of MedChemNet

MedChemNet

A network for the medicinal chemistry community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.